Akorn Inc - Company & Market Research Reports

Akorn pharmaceutical is a specialised company that develops niche generic and branded pharmaceuticals, over-the-counter drug products and animal health products internationally and in the U.S. The company was founded in 1971 and is headquartered in Lake Forest, Illinois. The Prescription Pharmaceuticals segment offers generic and branded prescription pharmaceuticals in various dosage forms, including sterile ophthalmics, injectables, and inhalants. The Consumer Health segment manufactures and markets OTC products. This segment offers a portfolio of animal health products, such as Anased and VetaKet veterinary sedatives; Tolazine and Yobine sedative reversing agents; and Butorphic, a pain reliever.

Specialty Generics Market Analysis By Type, By End-use, And Segment Forecasts, 2014 - 2025 - Product Thumbnail Image

Specialty Generics Market Analysis By Type, By End-use, And Segment Forecasts, 2014 - 2025

  • Report
  • 101 Pages
From
Global Antihistamines Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026 - Product Thumbnail Image

Global Antihistamines Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • Report
From
Bacterial Conjunctivitis Treatment Market: By Infection; By Antibacterial Class; By Method & By Geography - Forecast 2016-2021 - Product Thumbnail Image

Bacterial Conjunctivitis Treatment Market: By Infection; By Antibacterial Class; By Method & By Geography - Forecast 2016-2021

  • Report
  • 135 Pages
From
Guide to U.S. Specialty Pharmaceutical Market: Companies, Products and Market Data - Product Thumbnail Image

Guide to U.S. Specialty Pharmaceutical Market: Companies, Products and Market Data

  • Report
  • 203 Pages
From
Artificial Tears - Global Strategic Business Report - Product Thumbnail Image

Artificial Tears - Global Strategic Business Report

  • Report
  • 143 Pages
From
Global Conjunctivitis Drugs Market 2018-2024 - Product Thumbnail Image

Global Conjunctivitis Drugs Market 2018-2024

  • Report
  • 82 Pages
From
Global Glaucoma Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025 - Product Thumbnail Image

Global Glaucoma Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • Report
From
Global Artificial Tears Market Research and Forecast 2018-2023 - Product Thumbnail Image

Global Artificial Tears Market Research and Forecast 2018-2023

  • Report
From
Global Glaucoma treatment Market Research and Forecast 2018-2023 - Product Thumbnail Image

Global Glaucoma treatment Market Research and Forecast 2018-2023

  • Report
From
Europe Artificial Tears Market Research and Forecast 2018-2023 - Product Thumbnail Image

Europe Artificial Tears Market Research and Forecast 2018-2023

  • Report
From
Global Glaucoma Treatment Drugs Market Forecast to 2020 - New Product Launches Expected to Boost Market - Product Thumbnail Image

Global Glaucoma Treatment Drugs Market Forecast to 2020 - New Product Launches Expected to Boost Market

  • Report
  • 150 Pages
From
Artificial Tears Market Analysis: By Type; By End-user age group - With Forecast 2016-2021 - Product Thumbnail Image

Artificial Tears Market Analysis: By Type; By End-user age group - With Forecast 2016-2021

  • Report
  • 155 Pages
From
Sufentanil Citrate Market: By Applications & By Geography - Forecast 2016-2021 - Product Thumbnail Image

Sufentanil Citrate Market: By Applications & By Geography - Forecast 2016-2021

  • Report
  • 149 Pages
From
Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report - Product Thumbnail Image

Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report

  • Report
  • 565 Pages
From
Acquisition of Akorn, Inc. and Merck KGaA’s Biosimilars Business by Fresenius SE & Co. KGaA Call - Fresenius SE & Co. KGaA - Earnings Transcript - Product Thumbnail Image

Acquisition of Akorn, Inc. and Merck KGaA’s Biosimilars Business by Fresenius SE & Co. KGaA Call - Fresenius SE & Co. KGaA - Earnings Transcript

  • Earnings Transcript
Q4 2016 Earnings Call - Akorn, Inc., - Earnings Transcript - Product Thumbnail Image

Q4 2016 Earnings Call - Akorn, Inc., - Earnings Transcript

  • Earnings Transcript
J.P. Morgan Health Care Conference - Akorn, Inc., - Earnings Transcript - Product Thumbnail Image

J.P. Morgan Health Care Conference - Akorn, Inc., - Earnings Transcript

  • Earnings Transcript
Q3 2016 Earnings Call - Akorn, Inc., - Earnings Transcript - Product Thumbnail Image

Q3 2016 Earnings Call - Akorn, Inc., - Earnings Transcript

  • Earnings Transcript
Piper Jaffray Healthcare Conference - Akorn, Inc., - Earnings Transcript - Product Thumbnail Image

Piper Jaffray Healthcare Conference - Akorn, Inc., - Earnings Transcript

  • Earnings Transcript
Morgan Stanley Global Health Care Conference - Akorn, Inc. - Earnings Transcript - Product Thumbnail Image

Morgan Stanley Global Health Care Conference - Akorn, Inc. - Earnings Transcript

  • Earnings Transcript
Loading Indicator
adroll